In order to celebrate the accomplishments of the Centers for Disease Control and Prevention's (CDC) National Comprehensive Cancer Control Program (NCCCP), the Comprehensive Cancer Control National Partners (CCCNP) developed this Special Issue on Cancer Causes and Control. This, the third Special Issue on Comprehensive Cancer Control (CCC), is a reflection of 20 years of building successful partnerships to prevent and control cancer; planning and implementing strategic cancer control; collaborating to address national cancer prevention and control priorities; evaluating efforts; sharing successes; and, in later years, serving as a model for global cancer control planning and implementation. The CDC currently supports cancer control planning and implementation in all 50 states, the District of Columbia, eight tribes or tribal organizations, and seven Pacific Island Jurisdictions and U.S. territories through the NCCCP. CCC is an approach that brings together multi-sector partners to address the cancer burden in a community collectively by leveraging existing resources and identifying and addressing cancer related issues and needs. The Comprehensive Cancer Control National Partnership (CCCNP), a partnership of national organizations, has been committed to supporting comprehensive cancer control efforts since 1999. We summarize the efforts described in this Special Issue. We also describe opportunities and critical elements to continue the momentum for comprehensive cancer control well into the future.

Because cancer registry data provide a census of cancer cases, registry data can be used to: 1) define and monitor cancer incidence at the local, state, and national levels; 2) investigate patterns of cancer treatment; and 3) evaluate the effectiveness of public health efforts to prevent cancer cases and improve cancer survival. The purpose of this article is to provide a broad overview of the history of cancer surveillance programs in the United States, and illustrate the expanding ways in which cancer surveillance data are being made available and contributing to cancer control programs. The article describes the building of the cancer registry infrastructure and the successful coordination of efforts among the 2 federal agencies that support cancer registry programs, the Centers for Disease Control and Prevention and the National Cancer Institute, and the North American Association of Central Cancer Registries. The major US cancer control programs also are described, including the National Comprehensive Cancer Control Program, the National Breast and Cervical Cancer Early Detection Program, and the Colorectal Cancer Control Program. This overview illustrates how cancer registry data can inform public health actions to reduce disparities in cancer outcomes and may be instructional for a variety of cancer control professionals in the United States and in other countries. Cancer 2017;123:4969-76. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

PURPOSE/OBJECTIVES: To describe smoking and obesity prevalence among male and female cancer survivors in the United States.. DESIGN: Cross-sectional survey.. SETTING: Household interviews.. SAMPLE: 9,753 survey respondents who reported ever having a malignancy, excluding nonmelanoma skin cancers. . METHODS: Data from the National Health Interview Survey (2008-2012) were used to calculate weighted smoking status prevalence estimates. Cross-tabulations of smoking and weight status were produced, along with Wald chi-square tests and linear contrasts.. MAIN RESEARCH VARIABLES: Cancer history, smoking status, obesity status, gender, age, and age at diagnosis.. FINDINGS: Seventeen percent of cancer survivors reported current smoking. Female survivors had higher rates of current smoking than males, particularly in the youngest age category. Male survivors who currently smoked had lower obesity prevalence rates than males who previously smoked or never smoked. Among female survivors, 31% were obese and no significant differences were seen in obesity prevalence by smoking status for all ages combined. . CONCLUSIONS: The findings highlight the variation in smoking status and weight by age and gender. Smoking interventions may need to be targeted to address barriers specific to subgroups of cancer survivors.. IMPLICATIONS FOR NURSING: Nurses can be instrumental in ensuring that survivors receive comprehensive approaches to address both weight and tobacco use to avoid trading one risk for another.

Despite modest reductions in the incidence rates for many cancers in recent years,1 the absolute number of people who will be diagnosed with cancer and the number of cancer survivors are expected to increase substantially over the next few decades in the U.S., due to changing demographics, an aging population, and improvements in survival.2–4 Advances in treating childhood cancer have led to an increase in the number of adolescents and young adults who are cancer survivors, and the late effects of treatment can be substantial in this age group.5 Most cancer survivors, however, are older than age 65 years.6 The number of adults aged 65 and older is projected to increase in the U.S. from 48 million in 2015 to 74 million by 2030.7 In the war on cancer, cancer survivors are often wounded warriors with long-term sequelae needing to be managed together with other chronic conditions, such as hypertension, cardiovascular disease, and diabetes.8–10 In addition, cancer survivors may be at risk of developing other primary cancers because of shared etiologic risk factors or the consequences of radiation therapy or chemotherapy.11,12 The complex needs of the continually growing number of cancer survivors cannot be fully met by the current healthcare system.13–16 | CDC has used interdisciplinary approaches to address the public health needs of cancer survivors for more than a decade.17 This article highlights some of the future directions suggested by the research and programmatic activities described in this special supplement to improve the health of cancer survivors and the communities in which they live.

Gynecologic cancer confers a large burden among women in the United States. Several evidence-based interventions are available to reduce the incidence, morbidity, and mortality from these cancers. The National Comprehensive Cancer Control Program (NCCCP) is uniquely positioned to implement these interventions in the US population. This review discusses progress and future directions for the NCCCP in preventing and controlling gynecologic cancer.

Colorectal cancer (CRC) is the second leading cause of | cancer deaths in the United States, killing more nonsmokers than any other cancer.1 In 2006, more than 139,000 | people were diagnosed with CRC and more than 53,000 | died of the disease.2 Screening can effectively decrease | CRC incidence and mortality in 2 ways: first, unlike most | cancers, screening offers the opportunity to prevent cancer by removing premalignant polyps; second, screening | can detect CRC early when treatment is more effective.3,4 If | CRC is diagnosed at early stages, the 5-year survival rate is | more than 88%.5 In a modeling study to assess deaths | prevented through increased use of clinical preventive | services, Farley et al6 estimated that 1900 deaths could be | prevented for every 10% increase in CRC screening with a | colonoscopy.